| Ytd | -70.74% | |
| 1y | -88.08% |
| Open | 0.38 | Prev Close | 0.38 | Low | 0.38 | High | 0.40 | Mkt Cap | 5.81M |
| Vol | 129.80K | Avg Vol | 7.57M | EPS | -1.36 | P/E | -0.29 | Forward P/E | -0.56 |
| Beta | 1.93 | Short Ratio | 1.06 | Inst. Own | 2.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.44 | 200-d Avg | 1.02 | 1yr Est | 22.50 |
SNGX News
PRINCETON, N.J., Aug. 7, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Compa
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 41.1% to $0.09 during Frida
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.co
Thermostability, immunogenicity and efficacy data against related viruses provides firm starting poi
Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100
U.S. stocks traded mixed, Nasdaq down 0.3%. Dow up 0.59%, S&P 500 down 0.09%. Consumer discretio
US stocks mixed, Dow up 300 pts. Dow up 0.64%, NASDAQ down 0.34%. Consumer discretionary up 1.7%, en
Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares ro
Thermostability, immunogenicity and efficacy data against related virusesmay provide rapid starting
PRINCETON, N.J., May 8, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Compan
PRINCETON, N.J., April 28, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Com
HyBryte™ demonstrates more rapid and robust treatment response compared toValchlor ® during 12-week
Upcoming high-impact milestones include interim analysis in Q2 2026 and top-line results in H2 2026
PRINCETON, N.J., March 26, 2026 /PRNewswire/ --Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp
Highlighting Positive Results in Comparison to Valchlor ® and in Real-World Use PRINCETON, N.J., Mar
AUSTIN, Texas, March 19, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organ
PRINCETON, N.J., March 19, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Com
PRINCETON, N.J., March 10, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Com
PRINCETON, N.J., Feb. 26, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp
PRINCETON, N.J., Feb. 24, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp
PRINCETON, N.J., Feb. 12, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp
Soligenix Inc. (NASDAQ: SNGX - Get Free Report) was the target of a significant drop in short intere
Study results support advancing SGX945 in this difficult-to-treat orphan disease Results suggest pot
Soligenix, Inc. (NASDAQ: SNGX) on Wednesday announced extended results of its ongoing Phase 2a trial
Optimized Gel Formulation Demonstrates Clinical Success in Third Cohort of Patients PRINCETON, N.J.
Thursday's session saw 189 companies set new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Tuesday